查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2021709

穿戴式心电图监测设备市场预测至2034年：按设备类型、监测方法、技术、应用、最终用户和地区分類的全球分析

Wearable Cardiac Monitoring Devices Market Forecasts to 2034 - Global Analysis By Device Type, Monitoring Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球穿戴式心电图监测设备市场预计到 2026 年将达到 140 亿美元，并在预测期内以 21% 的复合年增长率增长，到 2034 年将达到 650 亿美元。

穿戴式心电图监测设备是携带式、佩戴于身上的技术，能够持续追踪心率、心率和电活动等心臟参数。这些设备包括智慧型手錶、贴片和携带式心电图仪，可提供即时数据和警报。它们有助于早期发现心臟异常，辅助慢性疾病管理，并提高患者参与度。与行动应用程式和医疗保健系统的集成，使临床医生能够进行远端监测。人们对心血管健康的日益关注以及穿戴式科技的进步，正在推动这些设备在全球的普及。

心血管疾病盛行率增加

随着心律不整、心臟衰竭和冠状动脉疾病的日益普遍，对持续且易于使用的监测解决方案的需求也日益增长。这些设备能够提供心率、心率和其他生命征象的即时讯息，从而实现异常情况的早期发现。其便携性和易用性使其适用于医院和居家照护。医疗保健专业人员正越来越多地采用穿戴式装置来改善患者预后并减少再入院率。随着心血管疾病成为全球性的健康挑战，对穿戴式监测解决方案的需求预计将持续强劲。

电池续航力和设备精度限制

持续监测需要设备长期运作，但电池容量的限制往往导致频繁充电。此外，数据准确性的波动，尤其是在消费级设备中，会降低临床可靠性。频繁充电会给患者带来不便，并可能影响依从性。製造商面临双重挑战：既要提高感测器精度，又要保持设备小巧的外形。儘管电池技术和感测器校准方面取得了进展，但这些挑战仍然是穿戴式装置广泛应用的障碍。

人工智慧驱动的即时心率监测

持续监测需要设备长时间运作，但电池容量的限制往往导致频繁充电。此外，数据准确性的波动，尤其是在消费级设备中，会降低临床可靠性。患者可能觉得频繁充电不便，进而影响顺从性。製造商面临双重挑战：既要提高感测器精度，也要保持设备紧凑的设计。儘管电池技术和感测器校准技术正在不断进步，但这些挑战仍然是设备广泛应用的障碍。

资料隐私与网路安全风险

穿戴式心率监测设备会收集高度敏感的健康讯息，因此极易遭受资料外洩和未授权存取。遵守 HIPAA 和 GDPR 等国际法规进一步增加了其普及的难度。患者可能因为担心个人健康数据被滥用而犹豫是否使用穿戴式装置。一旦发生资料洩露，医疗机构也将面临声誉和法律风险。供应商正在投资加密技术、安全的云端基础设施和先进的身份验证系统来降低这些风险。儘管采取了这些措施，网路安全问题仍然是推广应用程式的一大障碍。

新型冠状病毒（COVID-19）的影响：

新冠疫情加速了穿戴式心电图监测设备的普及。随着医院不堪重负，面对面就诊受到限制，远端监测成为心臟病患者管理的关键。穿戴式装置能够持续追踪心臟健康状况，进而减少患者就医次数。疫情期间，各国政府和医疗系统大力投资远端医疗和远距监测基础设施。疫情凸显了扩充性、以病人为中心的医疗技术在医疗服务中的重要性。后疫情时代，医疗机构将持续把穿戴式监测技术融入日常诊疗流程。

在预测期内，连续监测领域预计将占据最大的市场份额。

随着心血管疾病盛行率的上升，对持续心臟监测解决方案的需求日益增长，预计在预测期内，持续监测领域将占据最大的市场份额。这些设备可提供心率、心率和其他重要参数的即时数据，从而实现异常情况的早期发现。医院和诊所越来越依赖持续监测来管理高风险患者。感测器技术和无线连接的进步正在提高设备的性能和可靠性。对于患者而言，这带来了许多益处，例如更高的便利性和更少的就医次数。透过与远端医疗平台的集成，持续监测的效用得到了进一步提升。

预计在预测期内，基于人工智慧的分析领域将呈现最高的复合年增长率。

在预测期内，人工智慧分析领域预计将呈现最高的成长率，这主要得益于心血管疾病盛行率的不断上升以及由此带来的对预测性和个人化监测解决方案日益增长的需求。人工智慧演算法能够分析大量的心臟数据，从而检测心律不整、预测不利事件并提供针对特定患者的建议。医生可受益于自动化警报和更高的诊断准确性。患者则可透过个人化见解和预防性照护获得安心。此外，对数位健康和​​机器学习平台的投资增加也为该领域提供了支持。随着医疗保健系统对人工智慧的广泛应用，我们预计分析主导监测的普及率将大幅提升。

市占率最大的地区：

在预测期内，北美预计将占据最大的市场份额，这主要得益于其先进的医疗保健基础设施以及心血管疾病在总人口中日益增长的患病率。美国在穿戴式心电图监测设备的核准方面处于主导地位，这得益于其完善的报销体系和监管审批。市场主要企业总部均设在该地区，推动创新和商业化进程。心律不整、心臟衰竭和冠状动脉疾病的高发生率推动了对持续监测的需求。人工智慧和数位健康平台与穿戴式装置的深度融合也使该地区受益匪浅。持续加大研发投入和临床试验进一步巩固了其市场领导地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于医疗保健的快速数位化以及新兴经济体心血管疾病盛行率的上升。中国、印度和东南亚等国家对价格合理且易于使用的监控解决方案的需求日益增长。各国政府正在投资医疗基础设施并推广远端医疗计划，以解决医疗保健方面的不平等问题。本土製造商提供成本绩效的设备，从而促进了价格敏感型市场的普及。智慧型手机的普及和行动连线的改善正在加速穿戴式装置与数位平台的融合。人们对预防性医疗保健意识的提高也进一步推动了市场扩张。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域划分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球穿戴式心电图监测设备市场：依装置类型划分

  • 心电图监测
  • 心臟事件记录器
  • 心电图贴片
  • 具备心电图功能的智慧型手錶
  • 其他设备类型

第六章 全球穿戴式心电图监测设备市场：依监测方法划分

  • 持续监测
  • 间歇性监测
  • 即时监控
  • 远端监控
  • 其他监测方法

第七章 全球穿戴式心电图监测设备市场：依技术划分

  • 心电图（ECG）
  • 光电容积脉搏波描记法（PPG）
  • 人工智慧驱动的分析
  • 无线连线
  • 基于云端的监控
  • 其他技术

第八章 全球穿戴式心电图监测设备市场：依应用领域划分

  • 心律不整检测
  • 心率监测
  • 预防中风
  • 术后监测
  • 其他用途

第九章 全球穿戴式心电图监测设备市场：依最终用户划分

  • 医院
  • 循环系统诊所
  • 居家医疗环境
  • 门诊手术中心
  • 健身和健康用户
  • 其他最终用户

第十章 全球穿戴式心电图监测设备市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十一章 策略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十二章 产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十三章：公司简介

  • Apple Inc.
  • Google（Fitbit）
  • Garmin Ltd.
  • Medtronic plc
  • Philips Healthcare
  • GE HealthCare
  • iRhythm Technologies Inc.
  • AliveCor Inc.
  • Preventice Solutions
  • Nihon Kohden Corporation
  • Omron Healthcare Inc.
  • Qardio Inc.
  • Withings SA
  • Biotronik SE & Co. KG
  • BioTelemetry Inc.
  • Abbott Laboratories
Product Code: SMRC35103

According to Stratistics MRC, the Global Wearable Cardiac Monitoring Devices Market is accounted for $14 billion in 2026 and is expected to reach $65 billion by 2034 growing at a CAGR of 21% during the forecast period. Wearable Cardiac Monitoring Devices are portable, body-worn technologies that continuously track heart-related parameters such as heart rate, rhythm, and electrical activity. These devices include smartwatches, patches, and portable ECG monitors that provide real-time data and alerts. They enable early detection of cardiac abnormalities, support chronic disease management, and improve patient engagement. Integration with mobile applications and healthcare systems allows remote monitoring by clinicians. Growing awareness of cardiovascular health and advancements in wearable technology are driving adoption of these devices globally.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

Rising cases of arrhythmias, heart failure, and coronary artery disease have intensified the need for continuous, accessible monitoring solutions. These devices provide real-time insights into heart rate, rhythm, and other vital parameters, enabling early detection of irregularities. Their portability and ease of use make them suitable for both hospital-based and home-based care. Healthcare providers are increasingly adopting wearables to improve patient outcomes and reduce hospital readmissions. With cardiovascular disease emerging as a global health burden, the demand for wearable monitoring solutions is expected to remain strong.

Restraint:

Limited battery life and device accuracy

Continuous monitoring requires devices to function for extended periods, yet limited battery capacity often necessitates frequent recharging. In addition, inconsistencies in data accuracy, particularly in consumer-grade devices, can reduce clinical confidence. Patients may find frequent charging inconvenient, which impacts compliance. Manufacturers face the dual challenge of improving sensor precision while maintaining compact designs. Although advancements in battery technology and sensor calibration are underway, these issues remain barriers to widespread adoption.

Opportunity:

AI-based real-time cardiac monitoring

Continuous monitoring requires devices to function for extended periods, yet limited battery capacity often necessitates frequent recharging. In addition, inconsistencies in data accuracy, particularly in consumer-grade devices, can reduce clinical confidence. Patients may find frequent charging inconvenient, which impacts compliance. Manufacturers face the dual challenge of improving sensor precision while maintaining compact designs. Although advancements in battery technology and sensor calibration are underway, these issues remain barriers to widespread adoption.

Threat:

Data privacy and cybersecurity risks

The wearable cardiac monitoring devices collect sensitive health information, making them vulnerable to breaches and unauthorized access. Compliance with global regulations such as HIPAA and GDPR adds complexity to deployment. Patients may hesitate to adopt wearables if they fear misuse of personal health data. Healthcare providers also face reputational and legal risks in the event of breaches. Vendors are investing in encryption, secure cloud infrastructure, and advanced authentication systems to mitigate these risks. Despite these measures, cybersecurity concerns remain a persistent barrier to adoption.

Covid-19 Impact:

The COVID-19 pandemic accelerated the adoption of wearable cardiac monitoring devices. With hospitals overwhelmed and in-person consultations restricted, remote monitoring became critical for managing cardiac patients. Wearables enabled continuous tracking of heart health, reducing the need for hospital visits. Governments and healthcare systems invested heavily in telehealth and remote monitoring infrastructure during the crisis. The pandemic underscored the importance of scalable, patient-centric technologies in healthcare delivery. Even in the post-pandemic era, providers continue to integrate wearable monitoring into routine care.

The continuous monitoring segment is expected to be the largest during the forecast period

The continuous monitoring segment is expected to account for the largest market share during the forecast period as rising prevalence of cardiovascular diseases has intensified demand for uninterrupted cardiac tracking solutions. These devices provide real-time data on heart rate, rhythm, and other vital parameters, enabling early detection of abnormalities. Hospitals and clinics increasingly rely on continuous monitoring to manage high-risk patients. Advances in sensor technology and wireless connectivity are improving device performance and reliability. Patients benefit from enhanced convenience and reduced hospital visits. Integration with telehealth platforms further expands the utility of continuous monitoring.

The AI-based analytics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-based analytics segment is predicted to witness the highest growth rate due to the rising prevalence of cardiovascular diseases, which has driven demand for predictive and personalized monitoring solutions. AI algorithms can analyze large volumes of cardiac data to detect arrhythmias, predict adverse events, and provide tailored recommendations. Physicians benefit from automated alerts and improved diagnostic accuracy. Patients gain confidence through personalized insights and proactive care. The segment is also supported by increasing investments in digital health and machine learning platforms. As healthcare systems embrace AI, adoption of analytics-driven monitoring is expected to surge.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure and the rising prevalence of cardiovascular diseases across the population. The U.S. leads in adoption of wearable cardiac monitoring devices, supported by strong reimbursement frameworks and regulatory approvals. Major players in the market are headquartered in the region, driving innovation and commercialization. High incidence of arrhythmia, heart failure, and coronary artery disease fuels demand for continuous monitoring. The region also benefits from strong integration of AI and digital health platforms with wearable devices. Ongoing investments in R&D and clinical trials further strengthen market leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare digitization and the rising prevalence of cardiovascular diseases in emerging economies. Countries such as China, India, and Southeast Asia are witnessing increasing demand for affordable and accessible monitoring solutions. Governments are investing in healthcare infrastructure and promoting telehealth initiatives to improve equity. Local manufacturers are offering cost-effective devices, boosting adoption in price-sensitive markets. Growing smartphone penetration and mobile connectivity enhance integration of wearable devices with digital platforms. Rising awareness of preventive healthcare further supports market expansion.

Key players in the market

Some of the key players in Wearable Cardiac Monitoring Devices Market include Apple Inc., Google (Fitbit), Garmin Ltd., Medtronic plc, Philips Healthcare, GE HealthCare, iRhythm Technologies Inc., AliveCor Inc., Preventice Solutions, Nihon Kohden Corporation, Omron Healthcare Inc., Qardio Inc., Withings SA, Biotronik SE & Co. KG, BioTelemetry Inc. and Abbott Laboratories.

Key Developments:

In March 2026, Garmin introduced its Venu 3 smartwatch with enhanced ECG and heart rate variability monitoring. The device integrates with Garmin Connect for physician data sharing, expanding Garmin's footprint in regulated cardiac health tracking.

In September 2025, AliveCor expanded its KardiaMobile portfolio with FDA-cleared AI algorithms for early detection of atrial flutter and tachycardia. The device integrates with telehealth platforms, enabling patients to share ECG data directly with physicians. AliveCor continues to bridge consumer wearables with regulated cardiac diagnostics.

In June 2025, Apple expanded its Apple Watch health suite with FDA-cleared atrial fibrillation detection algorithms. The update integrates continuous ECG monitoring with AI-driven alerts, enabling early detection of irregular rhythms. Apple's innovation strengthens its role in consumer-driven cardiac monitoring, bridging lifestyle wearables with regulated medical-grade diagnostics.

Device Types Covered:

  • Holter Monitors
  • Event Monitors
  • ECG Patches
  • Smartwatches with ECG
  • Other Device Types

Monitoring Types Covered:

  • Continuous Monitoring
  • Intermittent Monitoring
  • Real-Time Monitoring
  • Remote Monitoring
  • Other Monitoring Types

Technologies Covered:

  • Electrocardiography (ECG)
  • Photoplethysmography (PPG)
  • AI-Based Analytics
  • Wireless Connectivity
  • Cloud-Based Monitoring
  • Other Technologies

Applications Covered:

  • Arrhythmia Detection
  • Heart Rate Monitoring
  • Stroke Prevention
  • Post-Surgical Monitoring
  • Other Applications

End Users Covered:

  • Hospitals
  • Cardiology Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Fitness & Wellness Users
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Wearable Cardiac Monitoring Devices Market, By Device Type

  • 5.1 Holter Monitors
  • 5.2 Event Monitors
  • 5.3 ECG Patches
  • 5.4 Smartwatches with ECG
  • 5.5 Other Device Types

6 Global Wearable Cardiac Monitoring Devices Market, By Monitoring Type

  • 6.1 Continuous Monitoring
  • 6.2 Intermittent Monitoring
  • 6.3 Real-Time Monitoring
  • 6.4 Remote Monitoring
  • 6.5 Other Monitoring Types

7 Global Wearable Cardiac Monitoring Devices Market, By Technology

  • 7.1 Electrocardiography (ECG)
  • 7.2 Photoplethysmography (PPG)
  • 7.3 AI-Based Analytics
  • 7.4 Wireless Connectivity
  • 7.5 Cloud-Based Monitoring
  • 7.6 Other Technologies

8 Global Wearable Cardiac Monitoring Devices Market, By Application

  • 8.1 Arrhythmia Detection
  • 8.2 Heart Rate Monitoring
  • 8.3 Stroke Prevention
  • 8.4 Post-Surgical Monitoring
  • 8.5 Other Applications

9 Global Wearable Cardiac Monitoring Devices Market, By End User

  • 9.1 Hospitals
  • 9.2 Cardiology Clinics
  • 9.3 Home Care Settings
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Fitness & Wellness Users
  • 9.6 Other End Users

10 Global Wearable Cardiac Monitoring Devices Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Apple Inc.
  • 13.2 Google (Fitbit)
  • 13.3 Garmin Ltd.
  • 13.4 Medtronic plc
  • 13.5 Philips Healthcare
  • 13.6 GE HealthCare
  • 13.7 iRhythm Technologies Inc.
  • 13.8 AliveCor Inc.
  • 13.9 Preventice Solutions
  • 13.10 Nihon Kohden Corporation
  • 13.11 Omron Healthcare Inc.
  • 13.12 Qardio Inc.
  • 13.13 Withings SA
  • 13.14 Biotronik SE & Co. KG
  • 13.15 BioTelemetry Inc.
  • 13.16 Abbott Laboratories

List of Tables

  • Table 1 Global Wearable Cardiac Monitoring Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Wearable Cardiac Monitoring Devices Market, By Device Type (2023-2034) ($MN)
  • Table 3 Global Wearable Cardiac Monitoring Devices Market, By Holter Monitors (2023-2034) ($MN)
  • Table 4 Global Wearable Cardiac Monitoring Devices Market, By Event Monitors (2023-2034) ($MN)
  • Table 5 Global Wearable Cardiac Monitoring Devices Market, By ECG Patches (2023-2034) ($MN)
  • Table 6 Global Wearable Cardiac Monitoring Devices Market, By Smartwatches with ECG (2023-2034) ($MN)
  • Table 7 Global Wearable Cardiac Monitoring Devices Market, By Other Device Types (2023-2034) ($MN)
  • Table 8 Global Wearable Cardiac Monitoring Devices Market, By Monitoring Type (2023-2034) ($MN)
  • Table 9 Global Wearable Cardiac Monitoring Devices Market, By Continuous Monitoring (2023-2034) ($MN)
  • Table 10 Global Wearable Cardiac Monitoring Devices Market, By Intermittent Monitoring (2023-2034) ($MN)
  • Table 11 Global Wearable Cardiac Monitoring Devices Market, By Real-Time Monitoring (2023-2034) ($MN)
  • Table 12 Global Wearable Cardiac Monitoring Devices Market, By Remote Monitoring (2023-2034) ($MN)
  • Table 13 Global Wearable Cardiac Monitoring Devices Market, By Other Monitoring Types (2023-2034) ($MN)
  • Table 14 Global Wearable Cardiac Monitoring Devices Market, By Technology (2023-2034) ($MN)
  • Table 15 Global Wearable Cardiac Monitoring Devices Market, By Electrocardiography (ECG) (2023-2034) ($MN)
  • Table 16 Global Wearable Cardiac Monitoring Devices Market, By Photoplethysmography (PPG) (2023-2034) ($MN)
  • Table 17 Global Wearable Cardiac Monitoring Devices Market, By AI-Based Analytics (2023-2034) ($MN)
  • Table 18 Global Wearable Cardiac Monitoring Devices Market, By Wireless Connectivity (2023-2034) ($MN)
  • Table 19 Global Wearable Cardiac Monitoring Devices Market, By Cloud-Based Monitoring (2023-2034) ($MN)
  • Table 20 Global Wearable Cardiac Monitoring Devices Market, By Other Technologies (2023-2034) ($MN)
  • Table 21 Global Wearable Cardiac Monitoring Devices Market, By Application (2023-2034) ($MN)
  • Table 22 Global Wearable Cardiac Monitoring Devices Market, By Arrhythmia Detection (2023-2034) ($MN)
  • Table 23 Global Wearable Cardiac Monitoring Devices Market, By Heart Rate Monitoring (2023-2034) ($MN)
  • Table 24 Global Wearable Cardiac Monitoring Devices Market, By Stroke Prevention (2023-2034) ($MN)
  • Table 25 Global Wearable Cardiac Monitoring Devices Market, By Post-Surgical Monitoring (2023-2034) ($MN)
  • Table 26 Global Wearable Cardiac Monitoring Devices Market, By Other Applications (2023-2034) ($MN)
  • Table 27 Global Wearable Cardiac Monitoring Devices Market, By End User (2023-2034) ($MN)
  • Table 28 Global Wearable Cardiac Monitoring Devices Market, By Hospitals (2023-2034) ($MN)
  • Table 29 Global Wearable Cardiac Monitoring Devices Market, By Cardiology Clinics (2023-2034) ($MN)
  • Table 30 Global Wearable Cardiac Monitoring Devices Market, By Home Care Settings (2023-2034) ($MN)
  • Table 31 Global Wearable Cardiac Monitoring Devices Market, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 32 Global Wearable Cardiac Monitoring Devices Market, By Fitness & Wellness Users (2023-2034) ($MN)
  • Table 33 Global Wearable Cardiac Monitoring Devices Market, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.